EQT, a private equity firm, agreed to invest $77m in BioGaia, an innovative Swedish healthcare company. “We have followed BioGaia for a long time and are impressed with the company’s 30-year long track record of probiotic innovation, growth and recent initiatives to digitalize its business, an area where EQT has vast experience. Biogaia’s focus on making a positive societal impact is also well aligned with EQT’s strategy of making purpose-driven investments. EQT Public Value looks forward to working together with shareholders, board and management on the next phase of BioGaia’s growth journey," Niklas Ringby, EQT Partners Co-Head of Public Value and Partner.